Myeloid-targeted immunotherapies act in synergy to induce inflammation and antitumor immunity.
Perry CJ, Muñoz-Rojas AR, Meeth KM, Kellman LN, Amezquita RA, Thakral D, Du VY, Wang JX, Damsky W, Kuhlmann AL, Sher JW, Bosenberg M, Miller-Jensen K, Kaech SM.
Perry CJ, et al. Among authors: damsky w.
J Exp Med. 2018 Mar 5;215(3):877-893. doi: 10.1084/jem.20171435. Epub 2018 Feb 7.
J Exp Med. 2018.
PMID: 29436395
Free PMC article.